ClinicalTrials.Veeva

Menu

PPI and Mindfulness App for Parents of Children with a NDD (Adappt)

U

University of Twente

Status

Enrolling

Conditions

Mental Well-being
Mental Health
Stress

Treatments

Other: Adappt

Study type

Interventional

Funder types

Other

Identifiers

NCT06248762
University of Twente

Details and patient eligibility

About

An app based on positive psychology and mindfulness to support the mental well-being of parents of children with a Neurodevelopmental Disorder (NDD) was developed and will be evaluated on effectiveness.

Full description

This pragmatic randomized controlled trial aims to assess the effectiveness of the Adappt app, an app developed to support the mental well-being of parents of children with a neurodevelopmental disorder (NDD), such as autism and ADHD. This app was developed since research has shown that these parents experience higher stress levels than parents of typically developing children. Furthermore, the app was developed in collaboration with parents of children with a NDD, mental health care professionals and scientists in Europe.

Enrollment

212 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. at least 18 years
  2. parent of one or more children (< 18 years) diagnosed with or suspected of a NDD
  3. having access to internet
  4. in possession of an e-mail address,
  5. in possession of a smartphone or tablet
  6. willing to use the digital intervention for a month, daily for approximately 15 minutes a day.

Exclusion criteria

  1. presence of severe anxiety symptoms
  2. presence of moderately severe to severe depressive symptoms
  3. being in treatment for mental health issues (the parent self)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

212 participants in 2 patient groups

Intervention condition
Experimental group
Description:
Participants will use the app for 4 weeks, daily for 10-15 minutes
Treatment:
Other: Adappt
Waitlist control condition
Other group
Description:
Participants in the control condition will start using the app 4 months after the start (baseline)
Treatment:
Other: Adappt

Trial contacts and locations

1

Loading...

Central trial contact

Ernst Bohlmeijer, Prof. Dr.; Kim Tönis, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems